Totally agree with you. What I see happening is that the flatpack is becoming a sustaining product and the revenues from its sales are all going in to support the operation. Gosh, what a terrible person someone must be to grant such an exclusive license and use the revenues to run the company. Wow, the horror! As flatpack sales continue to grow we are on the verge of things all coming together with the N-Assay, and that is potentially huge. Your analysis is right on.